LENZ (LENZ Therapeutics) FCF Margin %: -1,767.49% (As of Mar. 2026)


LENZ LENZ Therapeutics Inc LENZ
12 GF Score
Price $5.51
! 2 Warning Signs
View Full Analysis

What is LENZ Therapeutics FCF Margin %?

LENZ Therapeutics LENZ -1.25% 12 FCF Margin % is -1,767.49% as of Mar. 2026. GuruFocus rates LENZ with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, LENZ Therapeutics ranks worse than 69.76% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LENZ Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-33.60 Mil. LENZ Therapeutics's Revenue for the three months ended in Mar. 2026 was $1.90 Mil. Therefore, LENZ Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was -1,767.49%.

As of today, LENZ Therapeutics's current FCF Yield % is -50.61%.

The historical rank and industry rank for LENZ Therapeutics's FCF Margin % or its related term are showing as below:

LENZ' s FCF Margin % Range Over the Past 10 Years
Min: -416.59   Med: -197.12   Max: -27.52
Current: -416.59

During the past 5 years, the highest FCF Margin % of LENZ Therapeutics was -27.52%. The lowest was -416.59%. And the median was -197.12%.

LENZ's FCF Margin % is ranked worse than
69.76% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs LENZ: -416.59

LENZ Therapeutics FCF Margin % Related Terms

LENZ Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for LENZ Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LENZ Therapeutics FCF Margin % Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 -27.52 0.00 0.00 -366.71

LENZ Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -234.96 -72.22 -2,082.05 -1,767.49

LENZ vs CNXU, CHRS, SLGL: FCF Margin % Comparison

For the Biotechnology subindustry, LENZ Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LENZ Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LENZ Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where LENZ Therapeutics's FCF Margin % falls into.


LENZ
12GF Score
LENZ Therapeutics Inc LENZ
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LENZ Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

LENZ Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-69.997/19.088
=-366.71 %

LENZ Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-33.6/1.901
=-1,767.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,767.49% mean?
LENZ Therapeutics (LENZ) has a FCF Margin % of -1,767.49% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LENZ Therapeutics and its competitors. According to the industry distribution chart, LENZ Therapeutics ranks #669 out of 959 companies in the Biotechnology industry, placing it in the top 69.8%.
Is LENZ Therapeutics' FCF Margin % too high?
LENZ Therapeutics' current FCF Margin % is -1,767.49%. Based on the distribution chart, LENZ Therapeutics ranks #669 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, LENZ Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LENZ Therapeutics' FCF Margin % compare to CNXU and CHRS?
According to the Biotechnology industry distribution chart, LENZ Therapeutics ranks #669 out of 959 companies for FCF Margin %. This places LENZ Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LENZ Therapeutics and its competitors. LENZ Therapeutics's current FCF Margin % is -1,767.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LENZ Therapeutics stock overvalued right now?
LENZ Therapeutics (LENZ) has a current FCF Margin % of -1,767.49%. The current FCF Margin % is -1,767.49%. LENZ Therapeutics' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For LENZ Therapeutics (LENZ), the current FCF Margin % is -1,767.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LENZ Therapeutics Business Description

Address 201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
12GF Score

Get the complete analysis for LENZ

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.51
Price